Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. Revalia will lead the effort to build advanced AI-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback